Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “PGI Drug Discovery LLC”

16 pharma patents match "PGI Drug Discovery LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 16
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 16 pharmaceutical patents matching "PGI Drug Discovery LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

16 results for “PGI Drug Discovery LLC” · 30,257 patents in full index Clear search

  1. US 11958862

    Compounds and compositions and uses thereof

    PGI Drug Discovery LLC · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  2. US 11491133

    Heteroaryl-isochroman compounds and uses thereof

    PGI Drug Discovery LLC · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  3. US 11332462

    Heteroaryl compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted May 17, 2022 · Expires May 12, 2042

    granted
  4. US 11192885

    1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders

    PGI Drug Discovery LLC · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  5. US 11077090

    Compounds and compositions and uses thereof

    PGI Drug Discovery LLC · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  6. US 10927124

    Compounds and compositions and uses thereof

    PGI Drug Discovery LLC · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  7. US 10894033

    Multicyclic compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted
  8. US 10780074

    Compounds and uses thereof

    PGI Drug Discovery LLC · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted
  9. US 10556890

    Heteroaryl compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  10. US 10336732

    1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders

    PGI Drug Discovery LLC · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted
  11. US 10196403

    Compounds and compositions and uses thereof

    PGI Drug Discovery LLC · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted
  12. US 10189825

    Heteroaryl compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  13. US 10085968

    Multicyclic compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  14. US 9856238

    1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders

    PGI Drug Discovery LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  15. US 9758529

    Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders

    PGI Drug Discovery LLC · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  16. US 9351954

    Multicyclic compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted May 31, 2016 · Expires May 26, 2036

    granted